Fund Holdings — GENERAL ATLANTIC, L.P.

Total Portfolio Value:
$3.63B
Total Bought:
$846.37M
Total Sold:
$676.35M
Net Transaction:
+$170.02M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
DLocal LimitedCL A(DLO)63,906,69563,906,6950$532.98M$724.70M19.97%+$191.72M
Chime Financial, Inc.CL A(CHYM)019,208,760+19,208,760$0$662.89M18.26%+$662.89M
Alignment Healthcare, Inc.(ALHC)60,993,32343,993,323-17,000,000$1.14B$615.91M16.97%-$519.79M
XP Inc.CL A(XP)29,617,73325,517,733-4,100,000$407.24M$515.46M14.20%+$108.21M
Akero Therapeutics5,233,9895,733,989+500,000$211.87M$305.97M8.43%+$94.09M
Alkami Technology, Inc.(ALKT)9,645,3189,645,3180$253.19M$290.71M8.01%+$37.52M
Pharvaris
COM
7,531,2527,531,2520$118.24M$132.55M3.65%+$14.31M
Centessa PharmaceuticalsADS9,681,8189,681,8180$139.22M$127.22M3.51%-$12.01M
Webull Corporation(BULL)07,148,051+7,148,051$0$85.49M2.36%+$85.49M
European Wax CenterCL A
CLASS A COM
13,110,49213,110,4920$51.79M$73.81M2.03%+$22.03M
Royalty Pharma plcCL A(RPRX)1,500,0001,500,0000$46.70M$54.05M1.49%+$7.35M
Riskified Ltd.CL A(RSKD)5,324,9985,324,9980$24.60M$26.57M0.73%+$1.97M
AdageneADS3,825,9523,825,9520$5.82M$7.46M0.21%+$1.65M
Alumis01,297,530+1,297,530$0$3.89M0.11%+$3.89M
Grove Collaborative Holdings, Inc.CL A(GROV)2,474,8592,474,8590$3.34M$2.85M0.08%-$495.0K
Acelyrin2,695,3270-2,695,327$6.66M$0—-$6.66M
Immunocore Holdings plcADS(IMCR)1,261,6840-1,261,684$37.43M$0—-$37.43M
WishCL A609,6160-609,616$4.26M$0—-$4.26M
Page 1 of 1
GENERAL ATLANTIC, L.P. — 13F Holdings — Q2 2025 | TickerTrail